Trademarkia Logo

Canada

C$
OPEN UP THE FUTURE
REGISTERED

on 19 Apr 2017

Last Applicant/ Owned by

MITSUBISHI TANABE PHARMA CORPORATION

3-2-10, Dosho-machi Chuo-ku, Osaka-shiOsaka 541-8505

JP

Serial Number

1778389 filed on 20th Apr 2016

Registration Number

TMA968552 registered on 19th Apr 2017

Registration expiry Date

19th Apr 2032

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

OPEN UP THE FUTURE

Trademark usage description

pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human body; pharmace Read More

Classification Information


Class [005]
Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human body; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines for the treatment and diagnosis of neurological conditions namely brain injury, seize disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease and cerebral palsy; pharmaceutical preparations and substances for the treatment of viral, cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal related diseases and disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of the musculoskeletal system, namely connective tissues diseases, bone disease, spinal disease, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic disease; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's Huntington's disease, Parkinson's disease, cerebral palsy, brain injury, spinal cord injury, seizure disorder; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Antiallergic medicines; Antihypertensives; Hypoglycemic agents; Antidiabetic preparations; Pharmaceutical preparations for the prevention of diabetic nephropathy; Pharmaceutical preparations, namely, antiphlogistic agents; human vaccines; Pharmaceutical preparations for the treatment of autoimmune disease; Pharmaceutical preparations for the treatment of cerebral infarction; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical preparations for the treatment of erectile dysfunction.


Classification kind code

10

Mark Details


Serial Number

1778389

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 10th Mar 2017
Allowed
Submitted for opposition 51
on 10th Mar 2017
Allowance Notice Sent
Submitted for opposition 42
on 23rd Nov 2016
Advertised
Submitted for opposition 26
on 3rd Nov 2016
Approved
Submitted for opposition 27
on 13th Sept 2016
Approval Notice Sent
Submitted for opposition 22
on 24th May 2016
Search Recorded
Submitted for opposition 20
on 24th May 2016
Examiner's First Report
Submitted for opposition 31
on 22nd Apr 2016
Formalized
Submitted for opposition 1
on 21st Apr 2016
Created
Submitted for opposition 30
on 20th Apr 2016
Filed